We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.

PULMONARY DRUGS MARKET ANALYSIS

Pulmonary Drugs Market, by Drug Class (Inhaled Corticosteroids, Long Acting Beta-2 Agonists, Antihistamines, Vasodilators, and Others), by Application (Asthma & COPD, Allergic Rhinitis, Pulmonary Arterial Hypertension, Cystic Fibrosis, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and e-Commerce), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Jul 2022
Code : CMI1285
Pages :304
Formats :
Excel and PDF
Industry : Pharmaceutical

Market News

Global Pulmonary Drugs Market: Key Developments

In June 2021, Glenmark Pharmaceuticals Limited, a multinational pharmaceutical company, based in India, launched Tiotropium Bromide Dry Powder Inhaler, used in the treatment of chronic obstructive pulmonary disease (COPD), in the U.K., under the brand name – Tiogiva.